Shanghai Chlor-Alkali Chemical Co Ltd

Shanghai Chlor-Alkali Chemical Co Ltd has a market capitalization of 8.2 billion CNY and a price-to-earnings ratio of 9.51, which is below the industry median of 12.0. The company's price-to-book ratio of 0.88 suggests it is trading at a discount to its book value, while its enterprise value to EBITDA of 11.40 is in line with the industry median of 11.50. The company's liquidity position is rated as medium, with a current ratio of 0.89 and a negative net cash position after subtracting total debt.

The company's profitability metrics show a return on equity of 9.25% and a return on assets of 5.71%, both of which are below the industry median of 10.5% and 6.2%, respectively. Gross profit margin is 15.54%, and operating margin is 12.07%, both of which are in line with the industry median of 15.6% and 12.1%. The company's net income margin is 11.03%, slightly below the industry median of 11.5%.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's operating cash flow is 1.13 billion CNY, but its free cash flow is negative at -1.57 billion CNY, primarily due to high capital expenditures of -2.62 billion CNY.

The company's outlook for the current fiscal year shows a projected revenue growth of 3.5%, with a net income growth of 2.1%. For the next fiscal year, revenue is expected to grow by 4.0%, and net income is projected to increase by 3.0%. These growth rates are slightly below the industry median of 4.5% and 3.5%, respectively.

The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The company's debt-to-equity ratio of 0.27 is below the industry median of 0.35, indicating a relatively conservative capital structure.

Recent filings and transcripts indicate that the company is investing in new production facilities to expand its capacity in commodity chemicals. The company has also taken steps to reduce operating costs and improve efficiency. No major regulatory or legal issues have been disclosed in the latest filings.